Home › Urothelial (Transitional Cell) Carcinoma › Texas › Houston

Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Houston, TX

19 pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Houston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

Nagre-recruitObservasyonal na pag-aaral

UT MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07789119

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Nagre-recruitPhase 3

Houston Methodist Hospital, Houston
Methodist Willowbrook Hospital, Houston
Houston Methodist West Hospital, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06524544

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

University of Texas MD Anderson Cancer Center, Houston
NEXT Houston, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Nagre-recruitPhase 1

University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Nagre-recruitObservasyonal na pag-aaral

The University of Texas M.D. Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05874921

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Nagre-recruitPhase 1/2

Texas Oncology - Gulf Coast, Houston
Texas Oncology - Gulf Coast, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Nagre-recruitPhase 1

MD Anderson, Houston
NEXT Oncology Houston, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3

University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Nagre-recruitPhase 1

Oncology Consultants, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Nagre-recruitPhase 3

Houston Metro Urology (HMU) - Southwest Location, Houston
Lumi Research - Houston, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06774131

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Houston Methodist Hospital, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04895709

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Nagre-recruitPhase 2

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Nagre-recruitPhase 2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06695845

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Nagre-recruitPhase 1/2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07169734

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Nagre-recruitPhase 1

MDACC, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT07484022

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Nagre-recruit

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04693377

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Nagre-recruitPhase 1/2

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674

Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.